Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Kulkarni

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Blood Transfusion = Trasfusione Del Sangue|December 2, 2020
Molecular characterization of rare D--/D-- variants in individuals of Indian originSwati Kulkarni, Garima Mishra, Harita Maru, et al.
Medicine and Science in Sports and Exercise|December 27, 2022
Longitudinal Sedentary Time and Symptoms in Breast Cancer Patients during Chemotherapy Using Ecological Momentary AssessmentWhitney A Welch, Payton Solk, Lisa Auster-Gussman, et al.
Breast Cancer Research and Treatment|March 7, 2019
What does risk of future cancer mean to breast cancer patients?Karen Kaiser, Kenzie A Cameron, Jennifer Beaumont, et al.
Practical Radiation Oncology|March 10, 2017
Assessing long-term complications in patients undergoing immediate postmastectomy breast reconstruction and adjuvant radiationRyan Sacotte, Niel Fine, John Y Kim, et al.
Medical Oncology (Northwood, London, England)|February 1, 2022
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancerCaroline Hamm, Bre-Anne Fifield, Amin Kay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Clinical Pharmacology in Drug Development|June 12, 2019
Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy MalesAnnelieke C Kruithof, Rajinder Kumar, Jasper Stevens, et al.
Psycho-Oncology|September 21, 2021
Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examinationLisa A Auster-Gussman, Kara L Gavin, Juned Siddique, et al.
Breast Cancer Research and Treatment|January 23, 2025
A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancerCatherine Doyle, Ana Elisa Lohmann, Nayyer Iqbal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Blood Transfusion = Trasfusione Del Sangue|December 2, 2020
Molecular characterization of rare D--/D-- variants in individuals of Indian originSwati Kulkarni, Garima Mishra, Harita Maru, et al.
Medicine and Science in Sports and Exercise|December 27, 2022
Longitudinal Sedentary Time and Symptoms in Breast Cancer Patients during Chemotherapy Using Ecological Momentary AssessmentWhitney A Welch, Payton Solk, Lisa Auster-Gussman, et al.
Breast Cancer Research and Treatment|March 7, 2019
What does risk of future cancer mean to breast cancer patients?Karen Kaiser, Kenzie A Cameron, Jennifer Beaumont, et al.
Practical Radiation Oncology|March 10, 2017
Assessing long-term complications in patients undergoing immediate postmastectomy breast reconstruction and adjuvant radiationRyan Sacotte, Niel Fine, John Y Kim, et al.
Medical Oncology (Northwood, London, England)|February 1, 2022
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancerCaroline Hamm, Bre-Anne Fifield, Amin Kay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2019
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancerPayton Solk, Kara Gavin, Jason Fanning, et al.
Clinical Pharmacology in Drug Development|June 12, 2019
Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy MalesAnnelieke C Kruithof, Rajinder Kumar, Jasper Stevens, et al.
Psycho-Oncology|September 21, 2021
Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examinationLisa A Auster-Gussman, Kara L Gavin, Juned Siddique, et al.
Breast Cancer Research and Treatment|January 23, 2025
A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancerCatherine Doyle, Ana Elisa Lohmann, Nayyer Iqbal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.
Pageof 8